K

Kinnate Biopharma, Inc.

89 employees

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Precision Oncology
Therapeutics
Oncology
Medical
Biopharma
Drug Discovery
Cancer
Precision Medicine

Date founded

2018

Funding rounds raised

Total raised

$98M

from 15 investors over 15 rounds

K

Kinnate Biopharma, Inc. raised $98M on August 26, 2020

Investors: Leerink Partners LLC, Research Division, Nextech Invest, Surveyor Capital, Viking Global Investors, OrbiMed Advisors, Vida Ventures, LLC, Logos Global Management, LP and RA Capital Management, L.P.

K

Kinnate Biopharma, Inc. raised $75M on December 19, 2019

Investors: Eshelman Ventures, LLC, Nextech Invest, Vida Ventures, LLC, Foresite Capital and OrbiMed Advisors

K

Kinnate Biopharma, Inc. raised $22M on April 1, 2018

Investors: Eshelman Ventures, LLC and Foresite Capital

FAQ